Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Nov 23, 2010 vagelos p roy Director Automatic Sell 30,000 30.03
Jun 3, 2010 goldberg murray a Officer Automatic Sell 13,900 30.02
Jun 3, 2010 kolinski stuart Officer Automatic Sell 6,784 30.02
Nov 23, 2010 shooter eric m Director Automatic Sell 7,500 30.00
Feb 17, 2010 shooter eric m Director Automatic Sell 15,000 30.00
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Oct 6, 2010 brown michael s Director Automatic Sell 3,235 29.05
Jul 1, 2011 baker charles a Director Option Execute 11,000 28.81
Aug 10, 2011 baker charles a Director Option Execute 4,000 28.81
Jul 1, 2011 goldstein joseph l Director Option Execute 10,000 28.81
May 4, 2011 goldstein joseph l Director Option Execute 5,000 28.81
Nov 22, 2011 sing george l Director Option Execute 15,000 28.81
May 18, 2010 sing george l Director Buy 2,500 28.64
Jun 4, 2010 goldberg murray a Officer Automatic Sell 6,100 28.56 - 29.37
May 18, 2010 sing george l Director Buy 5,000 28.44
May 18, 2010 brown michael s Director Disposition (Non Open Market) 4,476 28.40
Oct 5, 2010 goldstein joseph l Director Automatic Sell 3,152 28.40
May 17, 2010 goldstein joseph l Director Sell 400 28.06
Oct 7, 2010 brown michael s Director Automatic Sell 1,765 28.03
Feb 3, 2010 goldberg murray a Officer Automatic Sell 13,895 28.02
Showing 261-280 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)